SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-031669
Filing Date
2023-11-13
Accepted
2023-11-13 16:52:34
Documents
22
Period of Report
2023-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20231112_8k.htm   iXBRL 8-K 34598
2 EXHIBIT 99.1 ex_595639.htm EX-99.1 164977
3 EXHIBIT 99.2 ex_595640.htm EX-99.2 4372
8 d01.jpg GRAPHIC 34970
9 d02.jpg GRAPHIC 62902
10 d03.jpg GRAPHIC 59379
11 d04.jpg GRAPHIC 62813
12 d05.jpg GRAPHIC 67469
13 d06.jpg GRAPHIC 75943
14 logo01.jpg GRAPHIC 8403
  Complete submission text file 0001437749-23-031669.txt   867159

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dmac-20231113.xsd EX-101.SCH 3410
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20231113_def.xml EX-101.DEF 11410
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20231113_lab.xml EX-101.LAB 15281
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20231113_pre.xml EX-101.PRE 11570
16 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20231112_8k_htm.xml XML 2559
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 231399729
SIC: 2834 Pharmaceutical Preparations